ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.3907C>T (p.Arg1303Ter)

dbSNP: rs1443114333
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000704815 SCV000833783 uncertain significance Hypertrophic cardiomyopathy 2022-05-26 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 581091). This premature translational stop signal has been observed in individual(s) with dilated cardiomyopathy (PMID: 25163546). This sequence change creates a premature translational stop signal (p.Arg1303*) in the MYH7 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MYH7 cause disease. This variant is present in population databases (no rsID available, gnomAD 0.0009%).
GeneDx RCV001775977 SCV002012579 uncertain significance not provided 2021-09-01 criteria provided, single submitter clinical testing Reported in a cohort of patients with sporadic or familial dilated cardiomyopathy, but detailed clinical and segregation information were not provided (Haas et al., 2015); Not observed at significant frequency in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; This variant is associated with the following publications: (PMID: 25163546)
Ambry Genetics RCV002369957 SCV002623944 uncertain significance Cardiovascular phenotype 2021-03-30 criteria provided, single submitter clinical testing The p.R1303* variant (also known as c.3907C>T), located in coding exon 27 of the MYH7 gene, results from a C to T substitution at nucleotide position 3907. This changes the amino acid from an arginine to a stop codon within coding exon 27. This variant has been reported in a dilated cardiomyopathy cohort; however, clinical details were limited (Haas J et al. Eur Heart J, 2015 May;36:1123-35a). This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of MYH7 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.